Transcriptome sequencing of the anterior cingulate in bipolar disorder: Dysregulation of G protein-coupled receptors

American Journal of Psychiatry

Volumn 172, Issue 11, 2015, Pages 1131-1140

  Cruceanu, Cristiana ^a   Tan, Powell Patrick Cheng ^a   Rogic, Sanja ^a   Lopez, Juan Pablo ^a   Torres Platas, Susana Gabriela ^a   Gigek, Carolina O ^a   Alda, Martin ^a   Rouleau, Guy A ^a   Pavlidis, Paul ^a   Turecki, Gustavo ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; G PROTEIN COUPLED RECEPTOR; LITHIUM SALT; MUSCARINIC M2 RECEPTOR; RELAXIN; SOMATOSTATIN RECEPTOR 2; TRANSCRIPTOME; UNTRANSLATED RNA; VALPROIC ACID; CHRM2 PROTEIN, HUMAN; LITHIUM DERIVATIVE; MESSENGER RNA; RECEPTOR; RXFP1 PROTEIN, HUMAN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR SUBTYPE 2, HUMAN; TRANQUILIZER;

ANTERIOR CINGULATE; ARTICLE; AUTOPSY; BIPOLAR DISORDER; CHRM2 GENE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; GENE; GENE EXPRESSION; GENE ONTOLOGY; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; NEURAL STEM CELL; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA SEQUENCE; RXFP1 GENE; SSTR2 GENE; ADULT; CASE CONTROL STUDY; CELL LINE; CINGULATE GYRUS; DRUG EFFECTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IN VITRO STUDY; METABOLISM; MIDDLE AGED; SEQUENCE ANALYSIS;

ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CASE-CONTROL STUDIES; CELL LINE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GYRUS CINGULI; HUMANS; IN VITRO TECHNIQUES; LITHIUM COMPOUNDS; MALE; MIDDLE AGED; NEURAL STEM CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, MUSCARINIC M2; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; RECEPTORS, SOMATOSTATIN; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; VALPROIC ACID;

EID: 84946114235     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.14101279     Document Type: Article

References (46)

1. Alda M, Hajek T, Calkin C, et al: Treatment of bipolar disorder: new perspectives. Ann Med 2009;41:186-196
2. Cruceanu C, Alda M, Rouleau G, et al: Response to treatment in bipolar disorder. Curr Opin Psychiatry 2011;24:24-28
3. Seifuddin F, Pirooznia M, Judy JT, et al: Systematic review of genome-wide gene expression studies of bipolar disorder. BMC Psychiatry 2013;13:213
4. Konradi C, Sillivan SE, Clay HB: Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosis. Neurobiol Dis 2012;45:37-47
5. Elashoff M, Higgs BW, Yolken RH, et al: Meta-analysis of 12 genomic studies in bipolar disorder. Journal Mol Neurosci 2007;31:221-243
6. Munkholm K, Vinberg M, Berk M, et al: State-related alterations of gene expression in bipolar disorder: a systematic review. Bipolar Disord 2012;14:684-696
7. Trapnell C, Williams BA, Pertea G, et al: Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010;28:511-515
8. Wang Z, Gerstein M, Snyder M: RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 2009;10:57-63
9. Cerullo MA, Adler CM, Delbello MP, et al: The functional neuroanatomy of bipolar disorder. Int Rev Psychiatry 2009;21:314-322
10. Lim CS, Baldessarini RJ, Vieta E, et al: Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 2013;37:418-435
11. Kim D, Pertea G, Trapnell C, et al: TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 2013;14:R36
12. Anders S, Pyl PT, Huber W: HTSeq: A Python framework to work with high-throughput sequencing data. Bioinformatics 2014; doi: http://dx.doi.org/10.1101/002824
13. Robinson MD, Oshlack A: A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 2010;11:R25
14. Law CW, Chen Y, Shi W, et al: voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol 2014;15:R29
15. Gillis J, Mistry M, Pavlidis P: Gene function analysis in complex data sets using ErmineJ. Nat Protoc 2010;5:1148-1159
16. Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, et al: An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012;489:391-399
17. Sheridan SD, Theriault KM, Reis SA, et al: Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS ONE 2011;6:e26203
18. Cruceanu C, Alda M, Nagy C, et al: H3K4tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression. Int J Neuropsychopharmacol 2013;16:289-299
19. Andersen CL, Jensen JL, Ørntoft TF: Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 2004;64:5245-5250
20. Kapranov P, St Laurent G, Raz T, et al: The majority of total nuclearencoded non-ribosomal RNA in a human cell is 'dark matter' unannotated RNA. BMC Biol 2010;8:149
21. Kim S, Webster MJ: The Stanley Neuropathology Consortium Integrative Database: a novel, web-based tool for exploring neuropathological markers in psychiatric disorders and the biological processes associated with abnormalities of those markers. Neuropsychopharmacology 2010;35:473-482
22. Zhao Z, Xu J, Chen J, et al: Transcriptome sequencing and genomewide association analyses reveal lysosomal function and actin cytoskeleton remodeling in schizophrenia and bipolar disorder. Mol Psychiatry 2014
23. Akula N, Barb J, Jiang X, et al: RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms and GTPase binding in bipolar disorder. Mol Psychiatry 2014;19:1179-1185
24. Sequeira A, Mamdani F, Ernst C, et al: Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 2009;4:e6585
25. Ernst C, Dumoulin P, Cabot S, et al: SNAT1 and a family with high rates of suicidal behavior. Neuroscience 2009;162:415-422
26. Ernst C, Sequeira A, Klempan T, et al: Confirmation of regionspecific patterns of gene expression in the human brain. Neurogenetics 2007;8:219-224
27. Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, et al: Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 2012;149:1622-1634
28. Amado M, Almeida R, Carneiro F, et al: A family of human beta3-galactosyltransferases: characterization of four members of a UDPgalactose: beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1, 3-galactosyltransferase family. J Biol Chem 1998;273:12770-12778
29. Zhu D, Shen A, Wang Y, et al: Developmental regulation of beta-1, 3-galactosyltransferase-1 gene expression in mouse brain. FEBS Lett 2003;538:163-167
30. NIH MMRRCsbt. B3galt2 knock-out mouse. Bethesda, Md, NIH, 2014
31. Conn PJ, Christopoulos A, Lindsley CW: Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov 2009;8:41-54
32. Tomita H, Ziegler ME, Kim HB, et al: G protein-linked signaling pathways in bipolar and major depressive disorders. Front Genet 2013;4:297
33. Cannon DM, Klaver JK, Gandhi SK, et al: Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder. Mol Psychiatry 2011;16:407-418
34. Gibbons AS, Scarr E, McLean C, et al: Decreased muscarinic receptor binding in the frontal cortex of bipolar disorderand major depressive disorder subjects. J Affect Disord 2009;116:184-191
35. Beneyto M, Morris HM, Rovensky KC, et al: Lamina- and cellspecific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia. Neuropharmacology 2012;62:1598-1605
36. Nanda SA, Qi C, Roseboom PH, et al: Predator stress induces behavioral inhibition and amygdala somatostatin receptor 2 gene expression. Genes Brain Behav 2008;7:639-648
37. Reif A, Nguyen TT, Weissflog L, et al: DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders. Neuropsychopharmacology 2011;36:2318-2327
38. Stengel A, Rivier J, Taché Y: Modulation of the adaptive response to stressby brain activation of selective somatostatin receptor subtypes. Peptides 2013;42:70-77
39. Nyegaard M, Børglum AD, Bruun TG, et al: Novel polymorphisms in the somatostatin receptor 5 (SSTR5) gene associated with bipolar affective disorder. Mol Psychiatry 2002;7:745-754
40. Kato T: Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 2007;61:3-19
41. Ryan MM, Lockstone HE, Huffaker SJ, et al: Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes. Mol Psychiatry 2006;11:965-978
42. He Z, Bammann H, Han D, et al: Conserved expression of lincRNA during human and macaque prefrontal cortex development and maturation. RNA 2014;20:1103-1111
43. Ng SY, Bogu GK, Soh BS, et al: The long noncoding RNA RMST interacts with SOX2 to regulate neurogenesis. Mol Cell 2013;51:349-359
44. Earls LR, Westmoreland JJ, Zakharenko SS: Non-coding RNA regulation of synaptic plasticity and memory: implications for aging. Ageing Res Rev 2014;17:34-42
45. Van De V, Gordebeke PM, Khoshab N: Long non-coding RNAs in neurodevelopmental disorders. Front Mol Neurosci 2013;6:53
46. Wilkinson B, Campbell DB: Contribution of long noncoding RNAs to autism spectrum disorder risk. Int Rev Neurobiol 2013;113:35-59